NfL concentrations are non-specific to amyloid pathology and increase in non-AD degeneration, particularly in amyotrophic lateral sclerosis (ALS) and in FTD, as well as in cases with secondary neuronal damage [7,12]. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.